FDA product code PQO: Anti-Müllerian Hormone Test System
PQO is the FDA product code for anti-müllerian hormone test system. It is a Class II device, regulated under 21 CFR 862.1092 and reviewed by the Clinical Toxicology panel. FDA has cleared 4 510(k) submissions under PQO, 3 in the last five years, from 3 different applicants. The average 510(k) review took 300 days (median 305). 1 De Novo request was granted under it. FDA has posted 1 recall for PQO devices, 1 initiated in the last five years.
Definition
An Anti-Müllerian hormone test system is an in vitro diagnostic device intended to measure anti-Müllerian hormone in human serum and plasma. The test is intended to be used as an aid for assessing ovarian reserve in women.
Classification
| Field | Value |
|---|---|
| Device name | Anti-Müllerian Hormone Test System |
| Device class | Class II |
| Regulation | 21 CFR 862.1092 |
| Review panel | TX — Clinical Toxicology |
| Medical specialty | Clinical Chemistry |
| Premarket route | 510(k) |
510(k) clearances per year for PQO
| Year | Clearances | Avg. review days |
|---|---|---|
| 2017 | 1 | 264 |
| 2022 | 1 | 534 |
| 2023 | 2 | 202 |
Compare with all 510(k) review times · Search every PQO clearance
Top PQO applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Beckman Coulter, Inc. | 2 | 2023-02-03 |
| Siemens Healthcare Diagnostics, Inc. | 1 | 2023-06-02 |
| Roche Diagnostics | 1 | 2022-06-10 |
Most recent PQO clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K221801 | Siemens Healthcare Diagnostics, Inc. | ADVIA Centaur® Anti-Müllerian Hormone (AMH) | 2023-06-02 | 346 |
| K223679 | Beckman Coulter, Inc. | Access AMH | 2023-02-03 | 57 |
| K203757 | Roche Diagnostics | Elecsys AMH | 2022-06-10 | 534 |
| K170524 | Beckman Coulter, Inc. | Access AMH | 2017-11-13 | 264 |
Recalls for PQO devices
1 product recalls in 1 recall events; 1 initiated in the last five years and 1 still open. Most recent: 2025-11-03.
| Year | Recalls |
|---|---|
| 2025 | 1 |
Frequently asked questions
What is FDA product code PQO?
PQO is the FDA product code for anti-müllerian hormone test system. It is a Class II device, regulated under 21 CFR 862.1092 and reviewed by the Clinical Toxicology panel.
What device class is PQO?
Class II, regulation 21 CFR 862.1092. Typical premarket route: 510(k).
How long does a 510(k) take for product code PQO?
Across 4 cleared submissions the average was 300 days from receipt to decision (median 305).
Which companies have the most PQO clearances?
Beckman Coulter, Inc. (2); Siemens Healthcare Diagnostics, Inc. (1); Roche Diagnostics (1).
Have PQO devices been recalled?
Yes: 1 product recalls across 1 recall events; the most recent began 2025-11-03.
Next steps
- Run an FDA pathway report with predicate devices for product code PQO
- Run a recall and safety report across every PQO manufacturer
- Watch product code PQO for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Clinical Toxicology product codes · FDA product code lookup · 510(k) database search · 510(k) review times